Recent Comments

  • Sorry, my friend. I hope it turned out well in the end....

  • No position or opinion on this. Just for whatever its worth. Its one of the things that is an issue for me with these small miners, often next years paycheck depends on todays drill results. I imagine there are more than one way to make something look better than what it is. Whether that applies here or not I have no opinion....

  • $ERDCF just passing on some info i came across re Erdene. I don't really have the expertise to analyze drill results. This guy does. I understand that explorers invest a lot of money doing their exploring, and they have a lot of motivation to get happy drill results. This is from a couple month ago I believe. Here's the blog link: http://incakolanews.blogspot.co.at/search?updated-min=2017...

  • Excellent Thank you. I have had cataract surgery twice in same eye....

  • Cleveland, EYEG finished their P2 study on delivery of dexamethasone using iontophoresis delivery (EGP-437) to a pre op cataract surgery eye the day before the surgery, in 2012 and has not published the results. This drug with its delivery system doesn't work well used as a single dose. Patients do not like taking post-op drops and a method to safely obviate the necessity would go a long way towa...

  • I have followed these three since 2014. They have served a useful purpose for Arch shareholders. They have exercised a ton of 2019-2021 warrants for which I am very thankful....

  • Yes I'm well aware of CLQ / CTEQF business and backers. Just as impressive is Australia's largest super fund getting involved :) the top 20 btw is littered with 'big names' in the Australian share scene....

  • Not true see below. Note to self--do your own research and do not rely on others. See the three "bad boys" who invested the 6 million $. They are so confident in their game plan they doubled down in this private placement. TWICE the size of the 2015 and 2016 private placement. The three participated in the 2015 and the 2016 private placement but no where near $ 2 million a piece. They are reall...

  • They have a ton to sell. They did good today. It will be interesting. These people exercised 99.9% of 17 million A warrants that don't expire until 2019. Why? They were at $ .20 share and they were able to make great profit. They have exercised a lot of the 2020 warrants and the 2021 warrants....

  • this sounds like a bunch of Dhillon's pals Some of the holdings of anson and cvi (both with Cayman Island offices) http://www.secgems.com/c/0001649553/cvi-investments-inc http://www.secgems.com/c/all_sec_filings/0001491072/frigate-ventures-lp This is not necessarily a bad thing but they often go on to sell the shares on the open market quickly plus short an equivalent amount while keep the...

  • Dr.KSS thank you for all you do and the science insights you provide and keeping us away from the stay away biotechs, i rarely post but try to catch up with the emails. i am long on many of your recommendations and without this group i wouldn't have thought about investing in biotechs. thanks again for all you do and thanks to many of valuable insights from other members of the group as well. ...

  • I'd like to buy more shares, so I hope their selling presents us with a good price. Thanks Cleveland....

  • Thank you. You are correct. I was relying on another board which had it wrong. Foolish me !! So Anson, CVI and Intracoastal are part of the original 9 investors that got 3 warrants for 1 share in 2013 that did not work out as they thought. This created the opportunity for all of us to purchase. These three probably have "Blocker" provisions that prohibit them from going over 5%. Means they se...

  • $BMY np Maybe Carl Icahn started the rumor :) http://www.investors.com/news/technology/carl-icahn-reportedly-invests-in-potential-takeout-target-bristol-myers/?yptr=yahoo...

  • What was Kieth refering to about on investing in companies without a IPO and are privately owned but a person is able to invest in them. How is that done.? Or is that even possible?...

  • I will share the story, because it is kind of interesting. Call it fate, luck, karma, blessings, or something else.... starting dec/15 was a year of traveling for me, and I had a too large cash position, and was in costa rica investigating potential real estate. Since I was on 100% free time, it allowed me to do what I like to do and that is learn stuff that interests me. My mind requires num...

  • I use TD Ameritrade and they seem to have everything. Most of these penny stocks seem to be listed on the OTC markets. I think the size of it determines the rest, but there's a lot of em...OTCQB, OTCQX, OTC Pink, OTC Grey Market to name a few. Depending on your broker, they may give you access to some or all of them....

  • $ARTH Long Name of Purchaser: ANSON INVESTMENTS MASTER FUND LP Signature of Authorized Signatory of Purchaser: /s/ Amin Nathoo Name of Authorized Signatory: Amin Nathoo Title of Authorized Signatory: Advising Rep, Anson Advisors Inc. Email Address of Authorized Signatory: [Redacted] Facsimile Number of Authorized Signatory: [Redacted] Address for Notice to Purchaser: [Redacted] Address f...

  • $ARTH Long Per 8-K filing James R. Sulat and Trust participated in this offering and its 100K. Remaining 6 million comes from other parties. Pg 34...

  • Priority review vouchers: It seems wrong that these can be bought or sold. Seems like there should be some mechanism in place where the FDA can retract or expire them if left unused for their intended purpose or if P3 results don't meet endpoints. Wondering how Sarepta even got a PRV in the first place......

  • Cleveland, I believe this is the document you're referring to: http://ir.archtherapeutics.com/all-sec-filings/content/0001144204-17-009992/0001144204-17-009992.pdf But it looks like James Sulat only took 1.64% of the offering. --Anson Investments bought 3,333,333 shares. --CVI Investments bought 3,333,333 shares. --Intracoastal Capital bought 3,333,333 shares. --James Sulat's 3 trusts ...

  • $ARTH long, $GILD np. Keeping Things In Perspective Dept: From today's WSJ: "A lack of deal activity at Gilead Sciences Inc. has lately frustrated shareholders. But company executives know a bargain when they see one. The biotech giant purchased a priority review voucher from Sarepta Therapeutics for $125 million, in a transaction announced Tuesday. Gilead now is in possession of two such voucher...

  • I have the same question which how to find the co's offering these bargains at a fraction...

  • Thanks for such an informative post as most of yours are. I have followed much of your advice and it has put a lot of green in my portfolio. Soon to be long in $CTEQF but minus one of my thumbs:) Up of course!...

  • The published drill results this morning looked encouraging at 10 meters at 11.6 grams per metric ton. It's a hold for me....

  • The first time I signed up with this fraud he pushed Iceland bonds... You had to buy them in $250,000 increments. If course he never bought any... and guess what happened next. Those bonds were not worth the paper they were printed on. All of True Wealth readers who followed his magic advice lost every penny or is that dollars.. Lots of dollars. Then I foolishly signed up for another of his s...

  • It's confusing because Cellectar issued two set of warrants, both labelled "Series A" Kirz, you are referring to these: http://investor.cellectar.com/releasedetail.cfm?releaseid=933374 But $CLRBZ (long) are these: http://investor.cellectar.com/releasedetail.cfm?releaseid=966005...

  • Hi Tom I did not post it because my post would go into moderation. Go to the Arch website and look at SEC filings. It is Director James Sulat. Dr. ZKSS should call him. He owns more than Dr. Norchi !! Tell Peter she is only ten and he is much too old. The dream would be a You Tube video with Dr. ZKSS asking Dr. Norchi and James Sulat questions. It could be an interview on behalf of the Gumshoe...

  • Re: possible ray of hope for the follicly challenged, Doc, if there ever were a cure, it would easily make billions. I'd certainly pony up for a treatment ;-)...

  • YVR_Trader, in looking at the $CLRBZ series A warrants, I see they were reduced to $2.83 strike price from $28.30 after a 1 for 10 split. Just want to know how you came up with $3.04. Long $CLRBZ....

  • Interesting comment from Caruso in the article..... "Caruso says he believes the data could look even better on patients in the third cohort of the Phase 1 trial"......IMO this should serve as a catalyst for $CLRB . Long $CLRB $CLRBZ...

  • I foolishly subscribed to one of the option services. Fortunately, I paper traded in my account. Following all of his recommendations to the letter... over a year the account is in the hole. I am not a stranger to options, but many of his picks seem to be totally random without any analysis. Many lose money only one or two days after their recommendation. I would not normally post this recom...

  • Good point. Also, after today's offering, it looks like they have around 184 million fully diluted shares. Which gives the stock a fully diluted market cap of $127 million. Hardly an expensive price tag if you believe this device will someday be a standard tool in most operating rooms. And that's not even taking into consideration its other potential applications. long $ARTH...

  • I was long on January 20 also, the day the market turned. Unfortunately I entered some time before that....

  • Cleveland, does this "single Arch Director" happen to have a daughter of marriageable age ?...

  • GNMX: Aevi Genomic Medicine Announces Expansion of its Collaboration with The Children's Hospital of Philadelphia. http://tiny.cc/nu6djy Disclosure: FP $GNMX investor day tomorrow....

  • $ARTH.. how/where did you find that tidbit Obi-Wan (aka Cleveland)? That's a ringing endorsement in my book....

  • While Tesla will continue to be controversial, there won't be a lot of controversy on the need for cobalt, nickel, aluminum alloys using scandium, waste and water remediation, a cleaner environment, and economical mining technology. One company that does all these things is positioned pretty well. Carmakers are a dime a dozen. Tesla, Panasonic no position. Long CleanTeQ....

  • Squirrel is building a nice reference library on CleanTeQ, or on Ionic. Thanks, Squirrel....

  • So from the standpoint of a third party, CleanTeQ has the second largest cobalt deposit in Australia; and note that CleanTeQ's deposit is twice the grade. Note that this means if other things were equal, which they are not, CleanTeQ's cost of production would be 50% as much per unit produced than Ardea's....

  • Well, I don't know the actual cost per gram of silicon film used in current solar cells, but I don't think its anywhere near $2000/gram ... I would guess that its closer to $20/gram (maybe even less). So lets look at it from a Power output vs Cost of materials perspective. Even though a Nano-Dot solar panel generates 2 times the power, the cost is 100 times more. So the Nano-Dot technology cost...

  • If I could own the future growth of either company I would prefer CleanTeQ. Tesla is a pioneer, an exciting company; but capital is going to come into CleanTeQ in a tidal wave, while Tesla will have a lot of it going out. Every car company on earth will be on Tesla's heels. And they will all be using material that ultimately comes from CleanTeQ....

  • The Market's reaction to a strategic joint venture (SJV) is so difficult to decipher. Little MEIP has huge SJV with partner buying common stock also and stock does nothing. PTN same thing Except no investment in common stock by SJV which as I have previously written about some time ago is a negative but stock should not have gone down so much. Here is one where the stock more than doubles---ti...

  • A US road show in March...that would be great, if my position is big enough by then !...

  • Hi Johnnn...I looked for it quickly, it didn't come up. But the graphics in the presentation were slides from the CleanTeQ investor presentations on the CleanTeQ website. I'll keep an eye out for the video of Friedlands presentation, which was at an African mining conference called INDABA, in South Africa. That presentation is referred to by several authors of mining industry publications. ...

  • Dr. KSS MD PhD

    Agree Cleveland. First thing I've heard in a while that makes me consider enlarging my already bulky position in $ARTH. None of the usual rules apply here as regards size of investment or proportion of portfolio because this guys an insider. Oh to know what he knows....

  • I'm not sure, CB! I didn't see any announcements this morning, but I won't "look a gift horse in the mouth"! I'm still holding 1000 shares....

  • You were not alone... I reluctantly sold a third of my holdings in OWCP expecting a big sell-off! What caused the triple digit increase?...

  • $ARTH So a single Arch Director buys the entire Arch $ 6.1 million private placement and everyone here is negative? He also participated in the June 2015 and the May 2016 private placement.. In my book this is bullish. Oh he owns 17 + million options and warrants of Arch. And he has a long long biotech resume....

View More Articles